• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两性霉素B与阿尼芬净或卡泊芬净联合应用对……的体外相互作用及杀菌动力学

In Vitro Interaction and Killing-Kinetics of Amphotericin B Combined with Anidulafungin or Caspofungin against .

作者信息

Caballero Unai, Eraso Elena, Quindós Guillermo, Jauregizar Nerea

机构信息

Department of Pharmacology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.

Department of Immunology, Microbiology and Parasitology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.

出版信息

Pharmaceutics. 2021 Aug 25;13(9):1333. doi: 10.3390/pharmaceutics13091333.

DOI:10.3390/pharmaceutics13091333
PMID:34575409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8468219/
Abstract

Treatment of invasive infections caused by is challenging due to the limited therapeutic options. The combination of antifungal drugs may be an interesting and feasible approach to be investigated. The aim of this study was to examine the in vitro activity of amphotericin B in combination with anidulafungin or caspofungin against . In vitro static time-kill curve experiments were conducted for 48 h with different combinations of amphotericin B with anidulafungin or caspofungin against six blood isolates of . The antifungal activity of 0.5 mg/L of amphotericin B was limited against the six isolates of . Similarly, echinocandins alone had a negligible effect, even at the highest tested concentrations. By contrast, 1 mg/L of amphotericin B showed fungistatic activity. Synergy was rapidly achieved (8 h) with 0.5 mg/L of amphotericin B plus 2 mg/L of anidulafungin or caspofungin. These combinations lead to a sustained fungistatic effect, and the fungicidal endpoint was reached against some isolates. Additionally, ≥0.5 mg/L of either of the two echinocandins with 1 mg/L of amphotericin B resulted in fungicidal effect against all isolates. In conclusion, combinations of amphotericin B with anidulafungin or caspofungin provided greater killing with a lower dose requirement for amphotericin B compared to monotherapy, with synergistic and/or fungicidal outcomes.

摘要

由于治疗选择有限,治疗由[病原体名称未给出]引起的侵袭性感染具有挑战性。抗真菌药物联合使用可能是一种值得研究的有趣且可行的方法。本研究的目的是检测两性霉素B与阿尼芬净或卡泊芬净联合使用对[病原体名称未给出]的体外活性。用两性霉素B与阿尼芬净或卡泊芬净的不同组合对[病原体名称未给出]的六株血液分离株进行了48小时的体外静态时间杀菌曲线实验。0.5mg/L的两性霉素B对这六株[病原体名称未给出]分离株的抗真菌活性有限。同样,即使在最高测试浓度下,单独使用棘白菌素的效果也可忽略不计。相比之下,1mg/L的两性霉素B表现出抑菌活性。0.5mg/L的两性霉素B加2mg/L的阿尼芬净或卡泊芬净能迅速实现协同作用(8小时)。这些组合导致持续的抑菌效果,并且对一些[病原体名称未给出]分离株达到了杀菌终点。此外,两种棘白菌素中任一种≥0.5mg/L与1mg/L的两性霉素B联合使用对所有[病原体名称未给出]分离株均产生杀菌作用。总之,与单一疗法相比,两性霉素B与阿尼芬净或卡泊芬净联合使用能以更低的两性霉素B剂量需求实现更大的杀菌效果,并产生协同和/或杀菌结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c46e/8468219/2b5da2f3b1ef/pharmaceutics-13-01333-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c46e/8468219/6f4ab6253c9c/pharmaceutics-13-01333-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c46e/8468219/2b5da2f3b1ef/pharmaceutics-13-01333-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c46e/8468219/6f4ab6253c9c/pharmaceutics-13-01333-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c46e/8468219/2b5da2f3b1ef/pharmaceutics-13-01333-g002.jpg

相似文献

1
In Vitro Interaction and Killing-Kinetics of Amphotericin B Combined with Anidulafungin or Caspofungin against .两性霉素B与阿尼芬净或卡泊芬净联合应用对……的体外相互作用及杀菌动力学
Pharmaceutics. 2021 Aug 25;13(9):1333. doi: 10.3390/pharmaceutics13091333.
2
Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida auris.抗真菌药物阿尼芬净、卡泊芬净和两性霉素 B 对耳念珠菌的抗真菌活性和杀菌动力学。
J Antimicrob Chemother. 2019 Aug 1;74(8):2295-2302. doi: 10.1093/jac/dkz178.
3
Killing kinetics of anidulafungin, caspofungin and micafungin against Candida parapsilosis species complex: Evaluation of the fungicidal activity.阿尼芬净、卡泊芬净和米卡芬净对近平滑念珠菌复合种的杀菌动力学:杀真菌活性评估
Rev Iberoam Micol. 2019 Jan-Mar;36(1):24-29. doi: 10.1016/j.riam.2018.12.001. Epub 2019 Mar 2.
4
In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.通过美国国家临床实验室标准委员会(NCCLS)方法测定的阿尼芬净、米卡芬净(已获许可的药物)及研究性三唑类药物泊沙康唑对12052株真菌分离株的体外抗真菌活性:文献综述
Rev Iberoam Micol. 2003 Dec;20(4):121-36.
5
Examination of the in vitro fungicidal activity of echinocandins against Candida lusitaniae by time-killing methods.用时间杀菌法检测棘白菌素类对葡萄牙念珠菌的体外杀菌活性。
J Antimicrob Chemother. 2013 Apr;68(4):864-8. doi: 10.1093/jac/dks489. Epub 2012 Dec 9.
6
Activities of nine antifungal agents against Candida auris biofilms.九种抗真菌药物对耳念珠菌生物膜的活性。
Mycoses. 2021 Apr;64(4):381-384. doi: 10.1111/myc.13223. Epub 2020 Dec 13.
7
In Vitro and In Vivo Activity of Citral in Combination with Amphotericin B, Anidulafungin and Fluconazole against Isolates.柠檬醛与两性霉素B、阿尼芬净和氟康唑联合对分离株的体外和体内活性
J Fungi (Basel). 2023 Jun 6;9(6):648. doi: 10.3390/jof9060648.
8
In vitro combination of antifungal drugs with tacrolimus (FK506) holds promise against clinical Candida species, including Candida auris.体外联合使用抗真菌药物与他克莫司(FK506)有望对抗临床念珠菌属,包括耳念珠菌。
Med Mycol. 2023 Jul 6;61(7). doi: 10.1093/mmy/myad069.
9
Evaluation of Antifungal Drug Combinations against Multidrug-Resistant Candida auris Isolates from New York Outbreak.针对来自纽约疫情的多重耐药耳念珠菌分离株的抗真菌药物联合评估
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02195-19.
10
Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Clades in RPMI-1640 in the Absence and Presence of Human Serum.瑞扎芬净、阿尼芬净、卡泊芬净和米卡芬净在有无人血清情况下对RPMI-1640中四个进化枝的体外杀菌活性比较
Microorganisms. 2021 Apr 16;9(4):863. doi: 10.3390/microorganisms9040863.

引用本文的文献

1
The GPI-Anchored Aspartyl Proteases Encoded by the and Genes of and Their Role Under Stress Conditions.由[具体物种名称]的[具体基因名称]和[具体基因名称]编码的糖基磷脂酰肌醇锚定天冬氨酸蛋白酶及其在应激条件下的作用
J Fungi (Basel). 2025 Aug 1;11(8):573. doi: 10.3390/jof11080573.
2
: Epidemiology and Antifungal Strategy.流行病学与抗真菌策略
Annu Rev Med. 2025 Jan;76(1):57-67. doi: 10.1146/annurev-med-061523-021233. Epub 2025 Jan 16.
3
Overcoming amphotericin B resistance in using the antiemetic drug rolapitant.使用止吐药洛派丁胺克服两性霉素 B 耐药性。

本文引用的文献

1
In vitro and in vivo interaction of caspofungin with isavuconazole against Candida auris planktonic cells and biofilms.卡泊芬净与伊曲康唑对浮游细胞和生物膜的体外和体内相互作用对耳念珠菌的影响。
Med Mycol. 2021 Oct 4;59(10):1015-1023. doi: 10.1093/mmy/myab032.
2
Comparison of In Vitro Killing Activity of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Clades in RPMI-1640 in the Absence and Presence of Human Serum.瑞扎芬净、阿尼芬净、卡泊芬净和米卡芬净在有无人血清情况下对RPMI-1640中四个进化枝的体外杀菌活性比较
Microorganisms. 2021 Apr 16;9(4):863. doi: 10.3390/microorganisms9040863.
3
Virulence of from different clinical origins in and host models.
Antimicrob Agents Chemother. 2024 Nov 6;68(11):e0055624. doi: 10.1128/aac.00556-24. Epub 2024 Oct 10.
4
Synergistic action of synthetic peptides and amphotericin B causes disruption of the plasma membrane and cell wall in Candida albicans.合成肽与两性霉素 B 的协同作用导致白色念珠菌的质膜和细胞壁破裂。
Biosci Rep. 2024 Apr 24;44(4). doi: 10.1042/BSR20232075.
5
In Vitro Susceptibility Tests in the Context of Antifungal Resistance: Beyond Minimum Inhibitory Concentration in spp.抗真菌耐药背景下的体外药敏试验:超越某菌属的最低抑菌浓度
J Fungi (Basel). 2023 Dec 12;9(12):1188. doi: 10.3390/jof9121188.
6
Efficacy of the combination of amphotericin B and echinocandins against and in the host model.两性霉素 B 与棘白菌素类药物联合治疗和感染宿主模型的疗效。
Microbiol Spectr. 2024 Jan 11;12(1):e0208623. doi: 10.1128/spectrum.02086-23. Epub 2023 Nov 29.
7
Critical appraisal beyond clinical guidelines for intraabdominal candidiasis.超越临床指南的腹腔内念珠菌病的关键评估。
Crit Care. 2023 Oct 3;27(1):382. doi: 10.1186/s13054-023-04673-6.
8
In Vitro Killing Activities of Anidulafungin and Micafungin with and without Nikkomycin Z against Four Clades.阿尼芬净和米卡芬净在有或无尼可霉素Z的情况下对四个进化枝的体外杀菌活性
Pharmaceutics. 2023 Apr 29;15(5):1365. doi: 10.3390/pharmaceutics15051365.
9
Heightened Efficacy of Anidulafungin When Used in Combination with Manogepix or 5-Flucytosine against Candida auris .阿尼芬净与马尼康唑或 5-氟胞嘧啶联合使用对耳念珠菌的增效作用。
Antimicrob Agents Chemother. 2023 Jun 15;67(6):e0164522. doi: 10.1128/aac.01645-22. Epub 2023 May 10.
10
Navigating the New Reality: A Review of the Epidemiological, Clinical, and Microbiological Characteristics of , with a Focus on Children.应对新现实:关于[具体疾病名称未给出]的流行病学、临床和微生物学特征的综述,重点关注儿童。
J Fungi (Basel). 2023 Jan 28;9(2):176. doi: 10.3390/jof9020176.
来自不同临床来源的 在 和 宿主模型中的毒力。
Virulence. 2021 Dec;12(1):1063-1075. doi: 10.1080/21505594.2021.1908765.
4
In Vitro Synergistic Interactions of Isavuconazole and Echinocandins against .艾沙康唑与棘白菌素类药物对……的体外协同相互作用
Antibiotics (Basel). 2021 Mar 28;10(4):355. doi: 10.3390/antibiotics10040355.
5
Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program.在一项监测计划中对艾沙康唑或伏立康唑联合阿尼芬净的协同活性以及耳念珠菌的发生情况和基因特征进行评估。
Antimicrob Agents Chemother. 2021 Mar 18;65(4). doi: 10.1128/AAC.02031-20.
6
Multidrug-Resistant Candida auris Infections in Critically Ill Coronavirus Disease Patients, India, April-July 2020.2020 年 4 月至 7 月,印度新冠肺炎重症患者中出现耐多药念珠菌血症感染。
Emerg Infect Dis. 2020 Nov;26(11):2694-2696. doi: 10.3201/eid2611.203504. Epub 2020 Aug 27.
7
Relative Frequency of Paradoxical Growth and Trailing Effect with Caspofungin, Micafungin, Anidulafungin, and the Novel Echinocandin Rezafungin against Species.卡泊芬净、米卡芬净、阿尼芬净及新型棘白菌素瑞扎芬净对[具体物种]的矛盾生长和拖尾效应的相对频率
J Fungi (Basel). 2020 Aug 17;6(3):136. doi: 10.3390/jof6030136.
8
Comparison of pathogenicity of four clades in a neutropenic bloodstream infection murine model.中性粒细胞减少性血流感染小鼠模型中四个分支的致病性比较。
Emerg Microbes Infect. 2020 Dec;9(1):1160-1169. doi: 10.1080/22221751.2020.1771218.
9
Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses.利用群体基因组分析追踪耳念珠菌的进化历史和全球扩张。
mBio. 2020 Apr 28;11(2):e03364-19. doi: 10.1128/mBio.03364-19.
10
Evaluation of Antifungal Drug Combinations against Multidrug-Resistant Candida auris Isolates from New York Outbreak.针对来自纽约疫情的多重耐药耳念珠菌分离株的抗真菌药物联合评估
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02195-19.